Founded in 2014, pHLIP, Inc. is a Delaware-based company dedicated to pioneering peptide imaging for disease detection and treatment. The company’s core mission is to leverage its platform technology to target acidic tissues, which are often indicative of diseases such as cancer. By focusing on the unique acidic environment of cancer cells, pHLIP aims to improve the detection, treatment, and prevention of diseases in both human and veterinary medicine.
Notable figures affiliated with pHLIP include experts in the fields of biochemistry and oncology, though specific names are not provided. The company has achieved significant milestones in developing its pHLIP® agents, which have shown promise in targeting cancerous tissues effectively. The overall impact of pHLIP, Inc. lies in its innovative approach to disease targeting, potentially revolutionizing how certain diseases are detected and treated.